Champions Oncology Inc (CSBR) USD0.001

Sell:$5.80Buy:$7.80$0.28 (4.73%)

Prices delayed by at least 15 minutes
Sell:$5.80
Buy:$7.80
Change:$0.28 (4.73%)
Prices delayed by at least 15 minutes
Sell:$5.80
Buy:$7.80
Change:$0.28 (4.73%)
Prices delayed by at least 15 minutes

Company Information

About this company

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Key people

Ronnie Morris
Chief Executive Officer, Director
David Miller
Chief Financial Officer
Joel Ackerman
Independent Chairman of the Board
David Sidransky
Lead Independent Director
Robert Brainin
Independent Director
Philip Breitfeld
Independent Director
Daniel N. Mendelson
Independent Director
Click to see more

Key facts

  • EPIC
    CSBR
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US15870P3073
  • Market cap
    $81.86m
  • Employees
    210
  • Shares in issue
    13.95m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.